Will Avandia Hurt Life Insurance Rates For Diabetes?

August 2nd, 2007

The old axiom “the cure is worse than the disease” may hold some truth from a life insurance underwriting standpoint. I can’t imagine an underwriter that would give equal consideration to well controlled diabetes if the control is at the risk of a drug induced heart attack.

With the FDA voting 22 to 1 to allow continued sales of Avandia, it’s sure to be around for a while. Kind of a head scratcher when they also voted 20-3 to accept the evidence that Avandia increases the risk of heart attack.

I read some very good commentary on that issue by Bev Sklar who posts for The Diabetes Blog.

Bottom line, like interferon treatment for Hepatitis C, I would be surprised if more conservative underwriters don’t start looking at what drug keeps your hbA1c in check. Just one more argument for an independent life insurance agent who keeps check on subtle underwriting changes.

Share and Enjoy:
  • Digg
  • del.icio.us
  • Facebook
  • Google Bookmarks
  • RSS
  • StumbleUpon
  • Twitter
Related Posts

Entry Filed under: Independent agent, diabetes, heart attack, hepatitis, insurance, life insurance

Leave a Comment

Required

Required, hidden

Some HTML allowed:
<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

Trackback this post  |  Subscribe to the comments via RSS Feed


Calendar

August 2007
S M T W T F S
« Jul   Sep »
 1234
567891011
12131415161718
19202122232425
262728293031  

Most Recent Posts